A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes ...

A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.

GSK shares surged today following the pharmaceutical heavyweight's agreement to fork out up to $2.2bn (£1.68bn) to resolve allegations that its heartburn medication, Zantac, was carcinogenic. The ...

News Lawsuit Linking Zantac to Cancer Diagnoses Survives Fight Over Jurisdiction Waterbury Superior Court Judge W. Glen Pierson ruled that defendants, having registered to do business in ...

Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims that Zantac is linked to cancer.

GSK Wins Latest Trial Over Zantac Cancer Claims. More. Reuters. Zantac heartburn pills are seen in this picture illustration taken October 1, 2019. REUTERS/Brendan McDermid/Illustration.

The first jury trial to determine if Zantac causes cancer happened in Cook County in May. An 89-year-old Brookfield woman sued GSK and Boehringer Ingelheim, another drugmaker that sold Zantac. She ...

A Delaware judge dismissed GSK and other drugmakers' appeal, allowing over 70,000 lawsuits alleging Zantac causes cancer to proceed, with the companies needing Delaware Supreme Court approval to ...

Drugmakers' Appeal to End Zantac Cancer Lawsuits Rebuffed ... "Judge Medinilla resoundingly rejected GSK, Boehringer ... as a federal judge did in 2022 in about 50,000 claims centralized in ...

A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward. The ...

A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward. The ...

A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward. The ruling by ...